Cargando…

4125 Plan for a Retrospective Evaluation of a Multi-Modal Weight-centric Prediabetes Intervention.

OBJECTIVES/GOALS: To determine if a multi-modal, interdisciplinary intervention delivered to a group of prediabetic patients will result in reduced rates of diabetes progression. This project is a retrospective evaluation that will exam the feasibility and possibly efficacy of this intervention. MET...

Descripción completa

Detalles Bibliográficos
Autores principales: Manalac, Raoul J, Stewart, Tiffany, Ryan, Donna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8823653/
http://dx.doi.org/10.1017/cts.2020.136
_version_ 1784646848332431360
author Manalac, Raoul J
Stewart, Tiffany
Ryan, Donna
author_facet Manalac, Raoul J
Stewart, Tiffany
Ryan, Donna
author_sort Manalac, Raoul J
collection PubMed
description OBJECTIVES/GOALS: To determine if a multi-modal, interdisciplinary intervention delivered to a group of prediabetic patients will result in reduced rates of diabetes progression. This project is a retrospective evaluation that will exam the feasibility and possibly efficacy of this intervention. METHODS/STUDY POPULATION: We will evaluate outcomes of 50 participants for the clinic, aged 21-60 inclusive. Patients will have a Body Mass Index >25kg/m(2) with a diagnosis of prediabetes. Patients must be non-pregnant, using approved contraception, and agree to not become pregnant for 1 year after enrollment. After enrollment, the initial treatment period is for 1 year and includes a 12 week low calorie diet plan, a 6-month intensive behavioral and lifestyle modification plan followed by a 6 month behavior reinforcement extension. Weight management medications may be used if appropriate for the patient from a clinical perspective during the 6-month intensive behavioral/lifestyle modification. RESULTS/ANTICIPATED RESULTS: It is anticipated that there will be decreased weight with a mean weight loss goal of approximately >10%. Furthermore, it is expect that there will be improvement of other markers of metabolic disease. These include improvement of lipid values (LDL-C, HDL-C, Triglycerides, Total Cholesterol) as well as blood pressure with expected blood pressures of below 130/80 in greater than 50% of participants. Finally, It is expected that 50% or greater participants will have improvement of glycemic control. It is anticipated that greater than 50% of participants will have improvement of glycemic control and achieve normoglycemia. These values will be determined based upon fasting glucose or A1c. DISCUSSION/SIGNIFICANCE OF IMPACT: The significance of this intervention is enormous. By demonstrating feasibility in this trial, we can work toward both assessing efficacy and possibly dissemination of this model program. If these interventions provide durable changes at scale, this could help slow the epidemic of obesity and obesity related comorbid conditions.
format Online
Article
Text
id pubmed-8823653
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-88236532022-02-18 4125 Plan for a Retrospective Evaluation of a Multi-Modal Weight-centric Prediabetes Intervention. Manalac, Raoul J Stewart, Tiffany Ryan, Donna J Clin Transl Sci Clinical Epidemiology/Clinical Trial OBJECTIVES/GOALS: To determine if a multi-modal, interdisciplinary intervention delivered to a group of prediabetic patients will result in reduced rates of diabetes progression. This project is a retrospective evaluation that will exam the feasibility and possibly efficacy of this intervention. METHODS/STUDY POPULATION: We will evaluate outcomes of 50 participants for the clinic, aged 21-60 inclusive. Patients will have a Body Mass Index >25kg/m(2) with a diagnosis of prediabetes. Patients must be non-pregnant, using approved contraception, and agree to not become pregnant for 1 year after enrollment. After enrollment, the initial treatment period is for 1 year and includes a 12 week low calorie diet plan, a 6-month intensive behavioral and lifestyle modification plan followed by a 6 month behavior reinforcement extension. Weight management medications may be used if appropriate for the patient from a clinical perspective during the 6-month intensive behavioral/lifestyle modification. RESULTS/ANTICIPATED RESULTS: It is anticipated that there will be decreased weight with a mean weight loss goal of approximately >10%. Furthermore, it is expect that there will be improvement of other markers of metabolic disease. These include improvement of lipid values (LDL-C, HDL-C, Triglycerides, Total Cholesterol) as well as blood pressure with expected blood pressures of below 130/80 in greater than 50% of participants. Finally, It is expected that 50% or greater participants will have improvement of glycemic control. It is anticipated that greater than 50% of participants will have improvement of glycemic control and achieve normoglycemia. These values will be determined based upon fasting glucose or A1c. DISCUSSION/SIGNIFICANCE OF IMPACT: The significance of this intervention is enormous. By demonstrating feasibility in this trial, we can work toward both assessing efficacy and possibly dissemination of this model program. If these interventions provide durable changes at scale, this could help slow the epidemic of obesity and obesity related comorbid conditions. Cambridge University Press 2020-07-29 /pmc/articles/PMC8823653/ http://dx.doi.org/10.1017/cts.2020.136 Text en © The Association for Clinical and Translational Science 2020 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Epidemiology/Clinical Trial
Manalac, Raoul J
Stewart, Tiffany
Ryan, Donna
4125 Plan for a Retrospective Evaluation of a Multi-Modal Weight-centric Prediabetes Intervention.
title 4125 Plan for a Retrospective Evaluation of a Multi-Modal Weight-centric Prediabetes Intervention.
title_full 4125 Plan for a Retrospective Evaluation of a Multi-Modal Weight-centric Prediabetes Intervention.
title_fullStr 4125 Plan for a Retrospective Evaluation of a Multi-Modal Weight-centric Prediabetes Intervention.
title_full_unstemmed 4125 Plan for a Retrospective Evaluation of a Multi-Modal Weight-centric Prediabetes Intervention.
title_short 4125 Plan for a Retrospective Evaluation of a Multi-Modal Weight-centric Prediabetes Intervention.
title_sort 4125 plan for a retrospective evaluation of a multi-modal weight-centric prediabetes intervention.
topic Clinical Epidemiology/Clinical Trial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8823653/
http://dx.doi.org/10.1017/cts.2020.136
work_keys_str_mv AT manalacraoulj 4125planforaretrospectiveevaluationofamultimodalweightcentricprediabetesintervention
AT stewarttiffany 4125planforaretrospectiveevaluationofamultimodalweightcentricprediabetesintervention
AT ryandonna 4125planforaretrospectiveevaluationofamultimodalweightcentricprediabetesintervention